Recursion Pharmaceuticals (RXRX) closed at $6.67 in the latest trading session, marking a -1.91% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.28%. Meanwhile, the Dow gained 0.15%, and the Nasdaq, a tech-heavy index, added 0.15%. The biotechnology company's shares have seen a decrease of 12.93% over the last month, not keeping up with the Medical sector's gain of 0.38% and the S&P 500's gain of 2%. Market participants will be closely following the financial results ...